Possible Biomarker for immune checkpoint inhibitor

被引：0
|
作者：
Takeuchi, Yoshiko [1 ,2 ]
Nishikawa, Hiroyoshi [1 ,3 ,4 ]
机构：
[1] Natl Canc Ctr, Div Canc Immunol, EPOC, Tokyo, Japan
[2] Osaka Univ, Dept Resp Med Allergy & Rheumat Dis, Grad Sch Med, Suita, Osaka, Japan
[3] Natl Canc Ctr, Res Inst, Grp Frontier Sci, Div Canc Immunol, Tokyo, Japan
[4] Nagoya Univ, Grad Sch Med, Immunol Cellular Immunol, Nagoya, Aichi, Japan
来源：
ANNALS OF ONCOLOGY | 2017年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ISY8-3
引用
收藏
页码：20 / 20
页数：1
相关论文
共 50 条
  • [11] Serum cytokines as a biomarker for immune checkpoint inhibitor toxicity in patients with pleural mesothelioma
    Farooqi, Saima Jamil
    Zhao, Zhi
    Oejlert, asa Kristina
    Thunold, Solfrid
    Juul, Hedvig Vidarsdotter
    Bjaanaes, Maria Moksnes
    Horndalsveen, Henrik
    Nymoen, Hanne Marte Gjertsen
    Helland, Aslaug
    Haakensen, Vilde Drageset
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [12] Transcriptome-based Biomarker for guidance of Immune Checkpoint Inhibitor Therapy in Melanoma
    Rotter, B.
    Hirsch, B.
    Feist, L.
    Al-Boutros, T.
    Hummel, M.
    Assaf, C.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2023, 21 : 123 - 123
  • [13] Combined biomarker for prediction of response to an immune checkpoint inhibitor in metastatic gastric cancer
    Heo, You Jeong
    Kang, So Young
    Kim, Seung Tae
    Kang, Won Ki
    Lee, Jeeyun
    Kim, Kyoung-Mee
    PRECISION AND FUTURE MEDICINE, 2019, 3 (04): : 165 - +
  • [14] Changes of BCR Repertoire Are Predictive Biomarker for the Efficacy of Immune Checkpoint Inhibitor in NSCLC
    Azuma, K.
    Nakahara, Y.
    Matsuo, N.
    Ishii, H.
    Tokito, T.
    Murotani, K.
    Hoshino, T.
    Sasada, T.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S707 - S707
  • [15] Response to Immune Checkpoint Inhibitor Treatment in Advanced Cervical Cancer and Biomarker Study
    Shieh, Kevin R.
    Huang, Anna
    Xu, Yiqing
    FRONTIERS IN MEDICINE, 2021, 8
  • [16] Somatostatin Receptor 2: A Potential Predictive Biomarker for Immune Checkpoint Inhibitor Treatment
    Wang, Aoyun
    Yuan, Yixiao
    Chu, Han
    Gao, Yixing
    Jin, Zheng
    Jia, Qingzhu
    Zhu, Bo
    PATHOLOGY & ONCOLOGY RESEARCH, 2022, 28
  • [17] Immune checkpoint inhibitor-induced endocrinopathies: a possible indicator of improved survival
    Ornelas, Mariana
    Borges-Canha, Marta
    Gouveia, Pedro
    Ferreira, Margarida
    Resende, Eduarda
    Sa, Maritza
    Abreu, Silvestre
    ARCHIVES OF ENDOCRINOLOGY METABOLISM, 2023, 67 (06):
  • [18] Identification of NOTCH4 mutation as a response biomarker for immune checkpoint inhibitor therapy
    Long, Junyu
    Wang, Dongxu
    Yang, Xu
    Wang, Anqiang
    Lin, Yu
    Zheng, Mingjun
    Zhang, Haohai
    Sang, Xinting
    Wang, Hanping
    Hu, Ke
    Zhao, Haitao
    BMC MEDICINE, 2021, 19 (01)
  • [19] DNA damage and repair gene panel as a biomarker of immune checkpoint inhibitor response.
    Chen, Ming Huang
    Pan, Yi-Ru
    Wu, Chiao-En
    Yeh, Yi Chen
    Hung, Yi-Ping
    Chao, Yee
    Wang, Yu-Chao
    Lin, Chien-Hsing
    Hsieh, Jason Chia-Hsun
    Yeh, Chun-Nan
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [20] Identification of NOTCH4 mutation as a response biomarker for immune checkpoint inhibitor therapy
    Junyu Long
    Dongxu Wang
    Xu Yang
    Anqiang Wang
    Yu Lin
    Mingjun Zheng
    Haohai Zhang
    Xinting Sang
    Hanping Wang
    Ke Hu
    Haitao Zhao
    BMC Medicine, 19
12345